GD-11 for Injection in the Treatment of Acute Ischemic Stroke
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 980 participants.
Also called NCT06299579
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 980 participants
- Sponsor
- Registry
-
NCT06299579
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT06299579. Randomized; triple masking; primary purpose treatment. Start 2024-02-29 (actual); primary completion 2025-02-22 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- GD-11 for Injection in the Treatment of Acute Ischemic Stroke
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- GD-11 for injection test group
- Intervention (Drug)
- Placebo control group
- Lead sponsor
- Beijing Tiantan Hospital
- Collaborator
- Jiangsu Wangao Pharmaceutical Co. ltd
Record details
- Record id
cardio:ct-nct06299579- Content hash
a4dd077ba695aa4da15101659adf4d09b32df7d921f860c3aa946e65bdcdfec9